ClinicalTrials.Veeva

Menu

Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study

S

Schön Klinik Berchtesgadener Land

Status

Unknown

Conditions

Lung Diseases, Interstitial
Noninvasive Ventilation

Treatments

Other: non-invasive ventilation

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02377739
NIV-ILD

Details and patient eligibility

About

The efficiency of non-invasive ventilation (NIV) in hypercapnic patients with chronic obstructive pulmonary disease during pulmonary rehabilitation has been shown in numerous studies. There is only a limited number of therapeutic options for patients with severely progressed interstitial lung disease (ILD). The question whether chronic hypercapnic ILD-patients are able to profit from nocturnal NIV and thus increase their performance in physical training has been left unknown. Therefore, this study aims to evaluate the feasibility of the initialization of a NIV for hypercapnic ILD-patients during pulmonary rehabilitation.

Enrollment

30 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • confirmed diagnosis of Interstitial lung disease
  • Hypercapnia defined as carbon dioxide partial pressure ≥45 mmHg (at rest, night or activity)
  • already existing but not sufficient and regular use of non-invasive ventilation (≤3h/24h)
  • patients consent to participate in this trial

Exclusion criteria

  • acute pulmonary insufficiency (ph<7.35)
  • acute, clinically relevant heart disease
  • already existing and sufficient use of non-invasive ventilation (≥3h/24h)
  • Body-Mass-Index>30
  • obstructive sleep apnea
  • Intolerance to perform non-invasive ventilation
  • acute infection

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

non-invasive ventilation
Experimental group
Description:
patients will undergo about 14 nights of non-invasive ventilation during pulmonary rehabilitation
Treatment:
Other: non-invasive ventilation

Trial contacts and locations

1

Loading...

Central trial contact

Rainer Gloeckl, PhD; Klaus Kenn, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems